Graham Juan

Graham Juan is listed in filings as CHIEF FINANCIAL OFFICER at Kyntra Bio, Inc.. This profile follows SEC Form 4 activity through Apr 1, 2025, including purchase activity. Recent filings connect the profile to Kyntra Bio, Inc. (KYNB) and Perspective Therapeutics, Inc. (CATX). The current snapshot covers public activity from Sep 9, 2024 to Apr 1, 2025. Reported amounts are shown as $415 to $365. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.